Tristel

TSTL.LSE
Healthcare · Medical Instruments & Supplies
420.00
+8.00 (+1.94%)
GBX · LSE

Company Information

Company Name
Tristel
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
LSE
ISIN: GB00B07RVT99
Currency: GBX
Full Time Employees: 270
Phone: 44 16 3872 1500
Fiscal Year End: June
IPO Date: Jun 01, 2005
Description:

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wipes, sporicidal wipes, clean for Stella, protect, and wipes; surface disinfection products, such as FUSE, JET, JET LUX, JET PRO, TANK 10 CLO2, TANK 5 CLO2, and TILT 5 CLO2; as well as operates 3T, a cloud-based platform alternative to paper-based traceability systems. The company provides its medical disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.

Address:

Lynx Business Park, Snailwell, United Kingdom, CB8 7NY

People

Directors & Officers

Name Title Year Born
Ms. Anna Katarzyna Wasyl Interim CEO, CFO & Director 1980
Emily Davey Global Marketing Director NA
Aimee Scarbrow Human Resources Director NA
Julija Shabanova Executive Director NA

Financial Highlights

Market Cap: $197.75M
EBITDA: $11.45M
P/E Ratio: $25.75
PEG Ratio: $0.00
Book Value: $0.70
Dividend/Share: $0.14
Dividend Yield: 3.16%
Earnings/Share: $0.16
Profit Margin: 15.88%
Operating Margin: 19.71%
ROA (TTM): 14.46%
ROE (TTM): 24.19%
Revenue (TTM): $49.54M
Revenue/Share (TTM): $1.04
Earnings Growth (YOY): 42.40%
Revenue Growth (YOY): 13.60%

Valuation Metrics

Enterprise Value: $208.52M
Trailing P/E: 25.75
Forward P/E: 23.20

Shares Statistics

Shares Outstanding: 48.00M
Shares Float: 46.10M
% Insiders: 236.30%
% Institutions: 5,021.90%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$46.46M
Cost of Goods Sold
adjust
$-8.52M
Gross Profit
subtotal
$37.94M
SG&A
adjust
$-24.97M
Other Operating Expense
adjust
$-4.57M
Operating Income
subtotal
$8.40M
Other / Non-Operating Items
adjust
$-1.76M
Net Income
subtotal
$6.64M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TSTL.LSE!